4//SEC Filing
Shanafelt Armen 4
Accession 0001140361-17-045128
CIK 0001636282other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 9:06 PM ET
Size
5.5 KB
Accession
0001140361-17-045128
Insider Transaction Report
Form 4
Shanafelt Armen
Director10% Owner
Transactions
- Award
Director Stock Option (right to buy)
2017-12-01+30,000→ 30,000 totalExercise: $4.73Exp: 2027-11-30→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning on January 1, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001656151
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 9:06 PM ET
- Size
- 5.5 KB